Cargando…

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human

Under the background of the severe human health and world economic burden caused by COVID-19, the attenuation of vaccine protection efficacy, and the prevalence and immune escape of emerging variants of concern (VOCs), the third dose of booster immunization has been put on the agenda. Systems biolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuwei, Yao, Mingxiao, Guo, Xingyu, Han, Shanshan, Zhang, Shu, Zhang, Jinzhong, Jiang, Xiangkun, Wang, Jianxing, Fang, Ming, Wang, Shuang, Pang, Bo, Liu, Xiaolin, Kou, Zengqiang, Jiang, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634958/ https://www.ncbi.nlm.nih.gov/pubmed/36341453 http://dx.doi.org/10.3389/fimmu.2022.1027180

Ejemplares similares

Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination
por: Zhang, Yuwei, et al.
Publicado: (2023)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine
por: Zhang, Yuwei, et al.
Publicado: (2022)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Investigation on an outbreak of cutaneous anthrax in a county of Shandong Province, China, 2021
por: Yu, Xiaolin, et al.
Publicado: (2022)

Epidemiological Characteristics of Human Rabies — Shandong Province, China, 2010–2020
por: Zhang, Xiaomei, et al.
Publicado: (2022)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers
por: Ma, Yifei, et al.
Publicado: (2022)

Epidemiological characteristics and spatio-temporal analysis of brucellosis in Shandong province, 2015–2021
por: Yu, Xiaolin, et al.
Publicado: (2023)

Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
por: Kobayashi, Mirei, et al.
Publicado: (2023)

Factors Associated With Severe Fever With Thrombocytopenia Syndrome in Endemic Areas of China
por: Jiang, Xiaolin, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
por: Zhu, Qian, et al.
Publicado: (2022)

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
por: Ai, Jingwen, et al.
Publicado: (2021)

Two Confirmed Patients of Anthrax — Binzhou City, Shandong Province, China, August 2021
por: Yu, Xiaolin, et al.
Publicado: (2021)

Sex, Attractiveness, and Third-Party Punishment in Fairness Consideration
por: Li, Jia, et al.
Publicado: (2014)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Transmission of SARS-CoV-2 Omicron Variant under a Dynamic Clearance Strategy in Shandong, China
por: Xu, Yifei, et al.
Publicado: (2023)

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2022)

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
por: Stahl, David, et al.
Publicado: (2022)

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
por: Zhu, Yajuan, et al.
Publicado: (2022)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study
por: Lin, Zhi-Qiang, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

Intestinal colonization with ESBL-producing Klebsiella pneumoniae in healthy rural villager: A genomic surveillance study in China, 2015-2017
por: Wang, Shuang, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio Better Than High-Sensitivity C-Reactive Protein in Predicting Stroke-Associated Pneumonia in Afebrile Patients
por: Wu, Ti, et al.
Publicado: (2021)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cuanmdptqo797d7ahck18l2l8f